Linked Life Data

10067106

Source:http://linkedlifedata.com/resource/pubmed/id/10067106

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-4-30
pubmed:abstractText
PET is recognized as a powerful imaging research tool. Based on pathophysiological and biochemical principles, functional PET imaging allows to assess parameters of tumor biology not easily accessible to conventional imaging such as metabolic activity, proliferation, adrenergic transmitter uptake or accumulation of cytostatic drugs in individual tumor manifestations. This article reviews recent developments of PET imaging with 2-[F-18]fluoro-deoxyglucose (FDG) in the Diagnosis of abdominal malignant tumors. Diagnosis of pancreatic carcinoma and its liver metastases, locoregional and distant recurrence as well as therapy control of colorectal cancer, nodal and extranodal staging and therapy monitoring of malignant lymphoma can be reliably achieved with PET. Encouraging clinical results and attractive new imaging concepts promise increasing use and importance of PET for imaging abdominal malignancies.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1661-8157
pubmed:author
pubmed:issnType
Print
pubmed:day
14
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
52-8, 60-4
pubmed:dateRevised
2008-6-10
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
[Current status of positron emission tomography in diagnosis of abdominal tumors].
pubmed:affiliation
Radiologische Universitätsklinik Ulm, Abteilung Radiologie III (Nuklearmedizin).
pubmed:publicationType
Journal Article, English Abstract, Review